Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults

NCT00094718 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

NIH

Sponsor class

Conditions

West Nile Fever Encephalitis

Interventions

BIOLOGICAL: WN/DEN4-3'delta30
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]